Ep. 214 Ken Shreve: Improving Portfolio Health With Medical Stocks
Investing With IBD
Dexcom DX, CM, and Inspire Medical: A Stock That's Coming Off a Sharp Selloff
Dexcom DX does continuous glucose monitoring for diabetics. The last two times it's reported, the stock has shot higher. It looks like contra funds slowly starts starting to increase their position over the last couple of quarters. I still think inspire is a stock that could be, could be discovered by more, more mutual funds.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
